Skip to main content

Cataracts & Macular Degeneration: Key Facts You Need to Know

Cataracts and macular degeneration are two of the most common age-related eye conditions, each affecting a different structure of the eye and producing distinct patterns of vision loss. A cataract is a clouding of the crystalline lens that obscures light passage to the retina, while macular degeneration damages the macula at the back of the eye, progressively eroding central vision.

This guide covers how each condition affects sight, their symptoms and risk factors, treatment options for both, and what to expect when the two conditions coexist.

Cataracts produce diffuse blurring across the entire visual field, progressing from mild cloudiness to glare sensitivity, halos around lights, and eventually severe opacity if untreated. Macular degeneration, by contrast, creates a central blind spot while leaving peripheral vision intact, with wet AMD capable of causing rapid deterioration within days or weeks.

Both conditions share modifiable risk factors, including smoking, UV radiation exposure, and systemic health issues such as obesity and hypertension. Age remains the dominant driver for each, though demographic factors like sex and ethnicity may also influence individual risk profiles.

Cataract surgery through phacoemulsification with intraocular lens implantation is the standard treatment for lens opacity, while AMD management ranges from anti-VEGF injections for wet AMD to complement-targeting therapies for geographic atrophy and AREDS2 supplementation for intermediate stages.

When both conditions are present simultaneously, cataract removal may still improve functional vision, though outcomes depend on the severity of underlying macular damage. Coordinated care between cataract and retinal specialists helps preserve as much sight as possible.

What Is a Cataract and How Does It Affect Vision?

A cataract is a clouding or opacification of the normally clear lens of the eye that obscures the passage of light through the lens to the retina. As the lens loses its transparency, light scatters instead of focusing cleanly, causing progressive visual disturbance. The following sub-sections cover how cataracts form at a cellular level, what vision changes they produce, and how symptoms evolve over time.

How Does a Cataract Form in the Eye?

A cataract forms when high molecular weight protein aggregates accumulate within the crystalline lens, causing light scattering and opacity rather than clear transmission, according to a review published in PubMed Central (NIH). The crystalline lens sits behind the iris and is nourished by the aqueous humor rather than direct blood supply, making it especially vulnerable to metabolic and oxidative changes over time. This structural breakdown is gradual, which is why many patients notice no symptoms in early stages.

What Vision Changes Does a Cataract Cause?

Cataracts cause a diffuse clouding or blurring across the entire visual field, distinguishing them clearly from conditions that affect only a portion of vision. Symptoms typically progress from mild blurriness to increased glare, halos around lights at night, and a phenomenon called “second sight,” where near vision temporarily improves due to nuclear sclerosis, as described in StatPearls (NCBI Bookshelf). Left untreated, the lens can become completely opaque, a state called hypermaturity, which may lead to secondary complications such as phacolytic glaucoma or lens-induced uveitis.

What Is Macular Degeneration and How Does It Affect Vision?

Macular degeneration is an age-related condition that damages the macula, the central portion of the retina, leading to progressive loss of central vision. The sections below cover how AMD impairs sight, the two primary forms it takes, and how quickly symptoms can progress.

What Does Central Vision Loss From Macular Degeneration Look Like?

Central vision loss from macular degeneration looks like a growing blind spot or distorted area directly in the center of what you see. According to the Webvision resource at the University of Utah, AMD affects the macula and causes loss of central vision while peripheral vision usually remains intact. Early signs may include colors appearing less vibrant and difficulty reading in low light. As the condition advances, a central scotoma can interfere with everyday tasks such as driving, reading, and recognizing faces. Wet AMD can cause this deterioration to occur within days or weeks, making prompt evaluation critical.

How Do Straight Lines Appear With Macular Degeneration?

Straight lines may appear wavy, bent, or distorted to someone with macular degeneration, a symptom known as metamorphopsia. This distortion occurs because photoreceptors in the macula become damaged or displaced as the disease progresses. According to the Cleveland Clinic, AMD progression also involves a gradual loss of fine detail alongside these visual distortions. Metamorphopsia is often one of the earliest functional complaints patients report and can be assessed at home using an Amsler grid.

When Do Macular Degeneration Symptoms Typically Begin?

Macular degeneration symptoms typically begin after age 50, with risk increasing significantly with each decade of life. Early stages are frequently asymptomatic, meaning vision may appear normal even when drusen deposits are already forming beneath the retinal pigment epithelium. Subtle changes, such as reduced color vibrancy or mild difficulty in dim lighting, often precede any noticeable blind spot. Because early AMD produces few obvious symptoms, many patients are unaware of the condition until it has advanced. A significant knowledge gap exists: only 17% of patients in one study reported understanding that AMD is a chronic condition requiring long-term management, according to a report in Physician’s Weekly.

How Are Cataracts Different From Macular Degeneration?

Cataracts and macular degeneration differ in the part of the eye they damage, the pattern of vision loss they cause, and the factors that drive them. The sections below cover how vision loss presents in each condition, which anatomical structures are involved, and how their causes compare.

How Does Vision Loss From Cataracts Differ From Macular Degeneration?

Vision loss from cataracts differs from macular degeneration in both its pattern and its underlying mechanism. Cataracts produce a diffuse clouding or blurring across the entire visual field, while AMD primarily causes a central scotoma, a blind spot in the center of vision, leaving peripheral sight largely intact, according to Healthline.

Cataract symptoms may also progress through distinct stages: mild blurriness, increased glare, halos around lights, and a temporary “second sight” improvement in near vision caused by nuclear sclerosis, per StatPearls. AMD, by contrast, erodes the ability to read, drive, or recognize faces without affecting the outer edges of sight at all.

When both conditions coexist, the outcome of cataract surgery depends heavily on the severity of the underlying macular degeneration and its impact on central vision.

Which Part of the Eye Does Each Condition Affect?

The parts of the eye affected by each condition are anatomically distinct. Cataracts affect the crystalline lens, located behind the iris, while macular degeneration affects the macula, the central portion of the retina at the back of the eye, according to Medical News Today.

Because the lens and retina serve entirely different functions in the visual pathway, damage to each produces a fundamentally different experience of vision loss. This anatomical distinction also explains why cataract surgery, which replaces the clouded lens, cannot restore vision already lost to retinal damage from AMD.

How Do the Causes of Cataracts Compare to Macular Degeneration?

The causes of cataracts and macular degeneration share some common ground but diverge significantly at the structural level. Cataracts result from protein aggregation within the crystalline lens, causing light scattering and opacity. Macular degeneration, by contrast, involves the accumulation of drusen deposits and lipofuscin in the retinal pigment epithelium, leading to progressive photoreceptor loss.

Leaving wet AMD untreated can lead to permanent scarring of the macula and irreversible central vision loss within a very short timeframe, per Mayo Clinic. Untreated cataracts follow a slower trajectory but can advance to hypermaturity, carrying risks of secondary complications.

Shared drivers, such as aging, UV exposure, and smoking, contribute to both conditions, but the biological processes causing harm differ at the tissue level.

What Are the Symptoms of Cataracts?

Cataract symptoms range from mild blurring in early stages to severe vision impairment if left untreated. The following sections cover how cataracts distort vision, their specific effects on night vision and glare, and when symptoms typically emerge.

What Does Blurry Vision From Cataracts Look Like?

Blurry vision from cataracts looks like a diffuse, overall cloudiness across the entire visual field, rather than a defined blind spot. Colors may appear yellowed or faded, and fine details become progressively harder to distinguish. According to StatPearls (NCBI Bookshelf), untreated cataracts can advance to hypermaturity, where the lens becomes completely opaque and may trigger serious secondary complications such as phacolytic glaucoma or lens-induced uveitis. Early blurring is easy to dismiss, but recognizing it as a potential cataract symptom matters for timely intervention.

How Do Cataracts Affect Night Vision and Glare?

Cataracts cause increased sensitivity to glare and produce halos around lights, particularly during nighttime driving. As the lens becomes cloudier, light scatters rather than focusing cleanly on the retina, making bright headlights or streetlights appear to bloom or streak. Some patients also notice a temporary improvement in near vision, known as “second sight,” which occurs as nuclear sclerosis shifts the eye’s refractive power before symptoms worsen further.

When Do Cataract Symptoms Typically Begin?

Cataract symptoms typically begin gradually, often starting after age 40 as natural protein changes within the lens accumulate over time. Initial symptoms, such as mild blurring or slight glare sensitivity, may be subtle enough to go unnoticed for years. Progression follows a slow course in most cases, advancing from mild cloudiness to halos around lights and eventually significant visual impairment if untreated.

What Are the Symptoms of Macular Degeneration?

The symptoms of macular degeneration center on the loss of central vision, distorted straight lines, and reduced ability to see fine detail. The sections below cover how central vision loss presents, how line distortion appears, and when symptoms typically begin.

What Does Central Vision Loss From Macular Degeneration Look Like?

Central vision loss from macular degeneration looks like a progressively darkening or blurred patch at the center of sight, while peripheral vision typically remains intact. According to the Cleveland Clinic, AMD progression is characterized by metamorphopsia (distorted straight lines), central scotomas (blind spots), and gradual loss of fine detail, with wet AMD capable of causing rapid vision loss within days or weeks.

Early signs can include colors appearing less vibrant and difficulty reading in low light. Over time, a central blind spot may interfere with everyday activities such as driving and recognizing faces. Untreated wet AMD can lead to permanent scarring of the macula (disciform scar) and irreversible central vision loss, according to Mayo Clinic. Central vision loss from AMD is often underestimated in urgency, particularly in the wet form where the window for intervention can close very quickly.

How Do Straight Lines Appear With Macular Degeneration?

Straight lines appear wavy, bent, or distorted to people with macular degeneration, a symptom clinically known as metamorphopsia. This occurs because damage to the macula disrupts how the retina processes the center of the visual field. A common self-monitoring tool is the Amsler grid, a simple checkerboard pattern that helps detect line distortion at home. Noticing this symptom and reporting it promptly to an eye care provider is important, as sudden worsening of line distortion may signal a shift toward wet AMD.

When Do Macular Degeneration Symptoms Typically Begin?

Macular degeneration symptoms typically begin subtly and are often missed in the early stages because peripheral vision remains unaffected. Early AMD may produce no noticeable symptoms at all, with drusen deposits identified only during a dilated eye exam. As the condition advances to intermediate or late AMD, symptoms such as difficulty reading in low light, color fading, and central blind spots become more apparent. Wet AMD can accelerate this process, with significant vision changes potentially appearing within days or weeks of abnormal blood vessel growth. Early and regular eye exams remain the most reliable way to catch AMD before symptoms become disabling.

What Are the Types of Macular Degeneration?

The types of macular degeneration are dry AMD and wet AMD, each differing in cause, progression speed, and severity of vision loss. The following sections cover how each type develops and what distinguishes them clinically.

Dry Macular Degeneration

Dry macular degeneration is the most common form of AMD, accounting for 85% to 90% of all cases. It is characterized by the accumulation of drusen deposits beneath the retinal pigment epithelium (RPE) and the gradual loss of photoreceptor cells. In its advanced stage, known as geographic atrophy, the RPE deteriorates in a defined area at least 175 µm in diameter, causing progressive central vision loss. Progression is typically slow, measured in years rather than weeks, which can make early detection difficult without routine eye examinations.

Wet Macular Degeneration

Wet macular degeneration, also called neovascular AMD, involves the abnormal growth of new blood vessels beneath the retina driven by elevated vascular endothelial growth factor (VEGF). According to a review published in the Journal of Clinical Medicine, VEGF upregulation triggered by hypoxia and inflammation induces choroidal neovascularization into the sub-RPE or subretinal spaces, causing fluid and blood leakage. Despite representing a minority of AMD cases, wet AMD is responsible for approximately 90% of AMD-related blindness. Vision loss can occur within days or weeks, making prompt treatment essential.

What Are the Risk Factors for Each Condition?

The risk factors for cataracts and macular degeneration overlap significantly, though each condition also carries distinct risk profiles. The following sections cover who is most vulnerable to cataracts, who faces the highest risk of AMD, and which risk factors both conditions share.

Who Is Most at Risk for Developing Cataracts?

The people most at risk for developing cataracts include older adults, smokers, individuals with long-duration diabetes, and those with prolonged UV radiation exposure. Smoking is a particularly well-documented hazard: according to a study published in the British Journal of Ophthalmology, smokers face a six times higher risk of developing dry AMD than nonsmokers, and smoking functions as a robust independent risk factor for cataracts as well. Females consistently show higher age-standardized cataract prevalence than males across all regions, further shaping who carries the greatest burden of disease.

Who Is Most at Risk for Developing Macular Degeneration?

The people most at risk for developing macular degeneration are older White adults, smokers, and individuals with a family history of AMD. Race plays a measurable role: adjusting for age and sex, Black individuals had a 70% lower risk of developing early AMD compared to White individuals in a multi-ethnic study published in Ophthalmology. Advanced age remains the dominant driver across all demographic groups, with risk rising sharply after age 60.

What Shared Risk Factors Apply to Both Conditions?

The shared risk factors for cataracts and AMD include advanced age, UV radiation exposure, smoking, genetic predisposition, and systemic conditions such as obesity and hypertension, according to a review published in Frontiers in Public Health. Because these modifiable factors affect both conditions simultaneously, addressing even one, such as quitting smoking or consistently wearing UV-protective eyewear, may reduce cumulative ocular risk across the board. From a clinical standpoint, patients managing multiple shared risk factors deserve early and regular screening for both conditions.

Can You Have Both Cataracts and Macular Degeneration at the Same Time?

Yes, you can have both cataracts and macular degeneration at the same time. Because both conditions share risk factors such as advanced age, smoking, and UV radiation exposure, they frequently develop together in older adults. The sections below cover how dual diagnosis affects vision and how doctors approach treatment when both are present.

How Does Having Both Conditions Affect Overall Vision?

Having both conditions affects overall vision by compounding distinct types of vision loss: cataracts produce diffuse clouding across the entire visual field, while AMD creates a central blind spot. Together, they can leave a person with blurred peripheral vision and a missing center, making everyday tasks such as reading, driving, and recognizing faces significantly harder. According to a 2020 study published in Nature Eye, an estimated 1.85 million people were blind due to AMD globally, with high-income countries accounting for 0.60 million of those cases. When AMD-related blindness is layered with cataract-related clouding, the combined burden on functional vision is especially severe.

How Do Doctors Manage Treatment When Both Are Present?

Doctors manage treatment when both conditions are present by prioritizing the condition causing greater functional impairment and sequencing interventions carefully. In most cases, cataract surgery is considered first if the lens opacity is limiting the ophthalmologist’s ability to assess or treat the retina. For coexisting AMD, anti-VEGF injections address neovascular disease, while AREDS2-based supplementation with lutein and zeaxanthin may be recommended for intermediate dry AMD. Lifestyle modifications, including smoking cessation, UV-protective sunglasses, and a diet rich in leafy green vegetables and omega-3 fatty acids, are advised for both conditions concurrently. Sequencing and monitoring require close coordination between cataract and retinal specialists to preserve as much functional vision as possible.

How Are Cataracts Treated?

Cataracts are treated primarily through surgery, which is the only proven method to restore vision lost from lens clouding. The sections below cover the standard surgical procedure and what patients can expect from outcomes.

What Is the Standard Surgical Treatment for Cataracts?

The standard surgical treatment for cataracts is phacoemulsification with intraocular lens (IOL) implantation. During this procedure, an ultrasonic probe breaks the clouded natural lens into fragments, which are then suctioned out and replaced with a clear artificial IOL. According to post-hoc analyses of AREDS data published in Ophthalmology Retina, most AMD patients also experience measurable vision improvement within 6 months of cataract surgery. The American Academy of Ophthalmology (AAO) does not recommend routine preoperative medical evaluations before cataract surgery unless the patient’s systemic health specifically warrants them.

What Happens If Cataracts Are Left Untreated?

Untreated cataracts can progress to hypermaturity, a state in which the lens becomes completely opaque. According to StatPearls (NCBI Bookshelf), this advanced stage may trigger serious secondary complications, including phacolytic glaucoma and lens-induced uveitis, both of which carry additional risks to long-term eye health. In practice, early surgical intervention is far simpler to manage than treating the compounding complications that hypermature cataracts can introduce.

How Is Macular Degeneration Treated?

Macular degeneration is treated differently depending on whether it is dry or wet AMD. The subsections below cover anti-VEGF injections for wet AMD, FDA-approved therapies for geographic atrophy, and nutritional supplementation for intermediate dry AMD.

How Is Wet AMD Treated?

Wet AMD is treated primarily with intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) drugs. According to a review published in the Journal of Clinical Medicine, the gold standard agents include bevacizumab, ranibizumab, aflibercept, brolucizumab, and faricimab. These injections target the VEGF pathway responsible for abnormal choroidal neovascularization, slowing fluid leakage and reducing vision loss. Early and consistent treatment is critical, as untreated wet AMD can lead to permanent macular scarring and irreversible central vision loss within a very short timeframe.

How Is Dry AMD (Geographic Atrophy) Treated?

Dry AMD at the geographic atrophy stage is treated with two FDA-approved intravitreal therapies: pegcetacoplan, which targets complement protein C3, and avacincaptad pegol, which targets C5. According to Mayo Clinic Proceedings: Innovations, Quality and Outcomes, both drugs are indicated to slow disease progression in advanced dry AMD. No therapy currently reverses geographic atrophy, making early diagnosis essential for preserving functional vision.

Can Nutritional Supplements Help Slow AMD Progression?

Nutritional supplements may help slow AMD progression in specific patients. According to the American Academy of Ophthalmology, the AREDS2 trial found that antioxidant vitamin and mineral supplementation, including lutein and zeaxanthin, should be considered for patients with intermediate AMD to reduce the risk of advancing to late-stage disease. Dr. Emily Y. Chew, MD, notes that “antioxidant and zinc supplementation decreases the risk of ARMD progression and vision loss” in this patient group. Supplements do not restore lost vision but can meaningfully alter the disease trajectory when started early.

What Are the Potential Risks of Untreated Cataracts or Macular Degeneration?

The potential risks of untreated cataracts or macular degeneration range from progressive vision loss to serious secondary complications that may become irreversible. Leaving either condition unmanaged significantly increases the likelihood of permanent visual disability.

Untreated cataracts can progress to hypermaturity, a stage in which the lens becomes completely opaque. According to StatPearls (NCBI Bookshelf), this advanced state may trigger secondary complications such as phacolytic glaucoma or lens-induced uveitis, both of which threaten long-term ocular health beyond vision impairment alone.

Untreated wet AMD carries a distinct and urgent risk profile. According to the Mayo Clinic, leaving wet AMD unmanaged can lead to permanent scarring of the macula, known as a disciform scar, resulting in irreversible loss of central vision within a very short timeframe. Unlike cataracts, which progress gradually, wet AMD can deteriorate within days or weeks.

From a preventive standpoint, the National Eye Institute identifies three modifiable risk-reduction strategies for both conditions:

  • Smoking cessation
  • UV protection through wearing sunglasses
  • A diet rich in leafy green vegetables and omega-3 fatty acids

Early intervention matters. Cataracts and wet AMD both respond to established treatments, but delayed care narrows the window for meaningful vision recovery, particularly in AMD where macula scarring is permanent.

Can Cataract Surgery Help if You Also Have Macular Degeneration?

Yes, cataract surgery can help when macular degeneration is also present, though outcomes depend on the severity of the AMD. The following sections cover how cataract removal may improve vision in AMD patients and what limitations to expect when both conditions coexist.

How May Cataract Removal Improve Vision With Existing Macular Degeneration?

Cataract removal may improve vision even when macular degeneration is present by clearing the clouded lens that compounds existing central vision loss. Phacoemulsification with intraocular lens (IOL) implantation is the standard surgical approach, and post-hoc analyses of AREDS data show that most AMD patients experience vision improvement six months after surgery. For patients with neovascular AMD already receiving intravitreal anti-VEGF injections, research published in Investigative Ophthalmology & Visual Science found that cataract surgery produced a beneficial effect on visual acuity without increasing the risk of geographic atrophy progression.

Dr. Julia Song, MD, notes that “timely diagnosis and management are critical” for preserving vision in patients with coexisting conditions like macular degeneration. In practice, removing the cataract first allows the retinal specialist to better assess and treat the underlying AMD, making early surgical planning especially valuable for this patient group.

What Are the Possible Limitations of Cataract Surgery When Macular Degeneration Is Present?

The possible limitations of cataract surgery when macular degeneration is present center on the extent of irreversible macular damage already sustained. Surgery can only address the lens opacity; it cannot restore retinal cells lost to AMD. When macular degeneration is advanced, particularly in cases of geographic atrophy or significant neovascular scarring, the improvement in central vision after cataract removal may be modest or minimal. According to the American Academy of Ophthalmology, surgical outcomes in this context are highly dependent on the severity of the underlying macular degeneration and its impact on central vision, making a thorough pre-operative retinal evaluation essential before proceeding.

How Can You Reduce Your Risk of Cataracts and Macular Degeneration?

You can reduce your risk of cataracts and macular degeneration through lifestyle modifications, UV protection, dietary changes, and targeted supplementation. The strategies below address shared and condition-specific risk factors.

The key risk-reduction approaches include:

  1. Quit smoking. Smoking is a robust independent risk factor for both conditions, and cessation directly lowers long-term risk.
  2. Wear UV-protective sunglasses. UV radiation exposure is a shared risk factor; quality sunglasses reduce cumulative lens and retinal damage.
  3. Eat a diet rich in leafy greens and omega-3 fatty acids. According to the National Eye Institute, these dietary patterns are among the primary preventive strategies for both cataracts and macular degeneration.
  4. Take targeted supplements if indicated. The AREDS2 trial found that antioxidant vitamin and mineral supplementation, including lutein and zeaxanthin, should be considered for patients with intermediate AMD to reduce the risk of progression to advanced stages.
  5. Manage systemic health. Controlling obesity and blood pressure may help lower overall risk, as both are shared comorbidities.
  6. Attend regular eye exams. Early detection allows timely intervention before significant vision loss occurs.

Proactively addressing modifiable risk factors is one of the most practical steps patients can take to protect long-term vision health.

How Can Surgeon-Reviewed Resources Help You Understand Your Vision Options?

Surgeon-reviewed resources can help you understand your vision options by translating complex clinical evidence into clear, actionable information. Eye Surgery Today covers cataract surgery fundamentals and key takeaways about both conditions.

Can Eye Surgery Today Help You Learn About Cataract Surgery and Vision Procedures?

Yes, Eye Surgery Today can help you learn about cataract surgery and vision procedures through surgeon-reviewed educational content designed for patients navigating treatable eye conditions. The platform covers topics including surgical candidacy, intraocular lens options, recovery expectations, and decision-making guidance, all presented without medical jargon.

Knowing what to expect before surgery matters. According to JAMA, the American Academy of Ophthalmology does not recommend routine preoperative medical evaluations before cataract surgery unless specifically indicated by a patient’s systemic health, meaning most patients can move forward without unnecessary delays.

What Are the Key Takeaways About Cataracts and Macular Degeneration?

The key takeaways about cataracts and macular degeneration are that both conditions are common, progressive, and manageable with early intervention. Cataracts affect the lens and are treatable with surgery, while macular degeneration affects the macula and requires ongoing monitoring or medical therapy. Shared risk factors include age, smoking, and UV exposure. Patients with both conditions can often still benefit from cataract surgery. Understanding the differences between these conditions empowers you to have more informed conversations with your care team about preserving long-term vision.

 

Skip to content